We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 21.77%
2 Healthcare 16.07%
3 Financials 11.39%
4 Consumer Discretionary 9.78%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RRGB icon
1076
Red Robin
RRGB
$137M
$460K ﹤0.01%
17,200
+10,600
+161% +$357K
THC icon
1077
Tenet Healthcare
THC
$21B
$459K ﹤0.01%
26,800
+10,900
+69% +$264K
WAT icon
1078
Waters Corp
WAT
$41B
$459K ﹤0.01%
2,436
-19,900
-89% -$3.78M
MGNI icon
1079
Magnite
MGNI
$3.4B
$452K ﹤0.01%
+121,200
New +$463K
CRZO
1080
DELISTED
Carrizo Oil & Gas Inc
CRZO
$452K ﹤0.01%
40,000
-158,300
-80% -$2.82M
BSV icon
1081
Vanguard Short-Term Bond ETF
BSV
$46.2B
$450K ﹤0.01%
5,730
+940
+20% +$73.3K
GOOS
1082
Canada Goose Holdings
GOOS
$724M
$450K ﹤0.01%
+10,300
New +$574K
RGEN icon
1083
Repligen
RGEN
$9.86B
$448K ﹤0.01%
+8,500
New +$499K
PACW
1084
DELISTED
PacWest Bancorp
PACW
$446K ﹤0.01%
+13,400
New +$534K
AVID
1085
DELISTED
Avid Technology Inc
AVID
$445K ﹤0.01%
+93,700
New +$540K
LCUT icon
1086
Lifetime Brands
LCUT
$191M
$442K ﹤0.01%
44,096
-3,200
-7% -$33.8K
HBAN icon
1087
Huntington Bancshares
HBAN
$33.8B
$441K ﹤0.01%
37,014
-41,500
-53% -$576K
AMD icon
1088
Advanced Micro Devices
AMD
$823B
$440K ﹤0.01%
+23,840
New +$515K
OPTU
1089
Optimum Communications Inc
OPTU
$377M
$434K ﹤0.01%
26,297
EXPE icon
1090
Expedia Group
EXPE
$35.2B
$434K ﹤0.01%
3,854
+937
+32% +$112K
SCM icon
1091
Stellus Capital Investment Corp
SCM
$226M
$434K ﹤0.01%
33,500
-13,200
-28% -$172K
PRFT
1092
DELISTED
Perficient Inc
PRFT
$434K ﹤0.01%
+19,500
New +$479K
HVT icon
1093
Haverty Furniture Companies
HVT
$426M
$431K ﹤0.01%
22,950
-4,300
-16% -$88.4K
NOC icon
1094
Northrop Grumman
NOC
$75.5B
$430K ﹤0.01%
1,756
-111,410
-98% -$30.8M
XOMA
1095
DELISTED
Xoma
XOMA
$430K ﹤0.01%
34,006
LUV icon
1096
Southwest Airlines
LUV
$19.2B
$429K ﹤0.01%
9,241
LGLV icon
1097
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
$1.2B
$427K ﹤0.01%
4,800
+460
+11% +$43K
ADTN icon
1098
Adtran
ADTN
$577M
$424K ﹤0.01%
+39,500
New +$538K
GD icon
1099
General Dynamics
GD
$97B
$423K ﹤0.01%
2,691
-818
-23% -$147K
NNN icon
1100
NNN REIT
NNN
$8.29B
$423K ﹤0.01%
8,712
-3,800
-30% -$181K

Similar funds

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.